TAK

Takeda Pharmaceutical Company Limited
D

TAK

12.960
USD
-0.15
(-1.11%)
مفتوح الان
حجم التداول
19,753
الربح لكل سهم
133
العائد الربحي
4.72
P/E
22
حجم السوق
41,087,880,996
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    -1.75
    (-0.64%)
    273.65 USD
    AZN
    AZN
    0.260
    (0.38%)
    68.230 USD
    GSK
    GSK
    -0.140
    (-0.41%)
    33.640 USD
    LLY
    LLY
    12.68
    (1.71%)
    755.35 USD
    MRK
    MRK
    0.070
    (0.07%)
    96.310 USD
    NVO
    NVO
    -0.045
    (-0.06%)
    80.880 USD
    PFE
    PFE
    -0.336
    (-1.26%)
    26.275 USD
    REGN
    REGN
    0.23
    (0.03%)
    687.55 USD
    SNY
    SNY
    -0.420
    (-0.81%)
    51.260 USD
    المزيد
الأخبار
المقالات

العنوان: Takeda Pharmaceutical Company Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.